NCT02412241View on ClinicalTrials.gov

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Oral Cavity CancerOropharyngeal CancerLymphedemaFibrosis
Interventions
OTHER

LEF measures

Patient-reported outcome measure; clinician-reported outcome measures

PROCEDURE

Technical measure

Undergo standard CT scan

PROCEDURE

Technical measure

Undergo standard ultrasound

Trial Locations (1)

37232

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT02412241 - Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients | Biotech Hunter | Biotech Hunter